1 to 10 of 15 Partnerships
Filtered by: 50519

Data for Health Initiative

Bangladesh, Brazil, China, Ecuador, Ghana, India, Indonesia, Malawi, Morocco, Myanmar, Papua New Guinea, Peru, Philippines, Rwanda, Solomon Islands, Sri Lanka, Tanzania, Zambia
USD 100 Million
Active

Building a Roadmap: Research Collaboration for Women’s Economic Empowerment

Completed

Business Call to Action

Active

Nuclear Threat Initiative

Worldwide
USD 1 Million
Active

Sanofi and MMV Partnership

Active

WIPO Re:Search

AL-JIHAD for Commerce and Contracting (JCC), GlaxoSmithKline (GSK), Management Sciences for Development (MSD), Novartis AG, Pfizer, Sanofi, 60 Degrees Pharmaceuticals, Aberystwyth University, Africa Fighting Malaria, African Institute of Biomedical Science and Technology (AiBST), Alnylam, Biotechnology Industry Organization (BIO), California Institute of Technology (Caltech), Chinese Center for Disease Control and Prevention (China CDC), The Center for World Health & Medicine (CWHM), Centre Pasteur du Cameroun (CPC), Council on Health Research for Development (COHRED), Developing World Health, Drugs for Neglected Diseases Initiative (DNDi), Emory University, European Commission (EC), Other - European Union, FIND Diagnostics, Oswaldo Cruz Foundation (Fiocruz), Global Alliance for Livestock Veterinary Medicines (GALVmed), Griffith University, Indian Council of Medical Research (ICMR), Infectious Disease Research Institute (IDRI), Institut Pasteur, International Centre for Genetic Engineering and Biotechnology (ICGEB), International Federation of Intellectual Property Attorneys (FICPI), International Hospital Federation (IHF), International Vaccine Institute (IVI), iThemba Pharmaceuticals, Kenya Medical Research Institute (KEMRI), Kenya Agricultural and Livestock Research Organization (KALRO), Kineta Inc., Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Licensing Executive Society International (LESI), Liverpool School of Tropical Medicine (LSTM), Mahidol University, Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), McGill University (Duplicate), McMaster University, Medicines for Malaria Venture (MMV), Murdoch Childrens Research Institute (MCRI), Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), National Institute of Immunology (NII), National University of Singapore, National Institute for Medical Research (NIMR), Tanzania, PATH Malaria Vaccine Initiative (MVI), Public Interest Intellectual Property Advisors (PIIPA), Sabin Vaccine Institute (Duplicate), Salvensis, Center for Infectious Disease Research, South African Medical Research Council (SAMRC), Stanford University (DUPLICATE), Swiss Tropical and Public Health Institute (Swiss TPH), The TTS Global Initiative, Tulane University, University of Bamako, University of Buea, University of Calgary, University of California, Berkeley, University of California, San Francisco, University of Dundee, The University of Edinburgh, University of Florida (UF), University of Ibadan, University of Kansas, University of Lagos, University of Mauritius, University of New South Wales (UNSW Australia), University of South Florida, University of Vermont, University of Washington (UW), University of Yaoundé, National Institutes of Health (NIH) - United States, US Patent and Trademark Office, Walter and Eliza Hall Institute of Medical Research (WEHI), Walter Reed Army Institute of Research (WRAIR)
Active

UltraRice

South Asia, India
USD 1.5 Million
Active

TB Drug Accelerator Program

Active

Sanofi and DNDi Partnership on Malaria

Active

Sanofi and DNDi Collaboration on Neglected Tropical Diseases

Worldwide
USD 75 Million
Active